Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
Gil-Chun ParkShin HwangChul-Soo AhnKi Hun KimDeok Bog MoonTae-Yong HaKi Won SongDong Hwan JungYoung In YoonHwui Dong ChoJae Hyun KwonYoung Kyu ChungSang Hyun KangJin Uk ChoiI Ji JungSung Gyu LeePublished in: Journal of Korean medical science (2020)
Our results suggest that patients who had pretransplant hepatic malignancy be followed up more strictly because they have a potential risk of primary hepatic malignancy recurrence as well as a higher risk of extrahepatic DNM than patients without pretransplant hepatic malignancy.